The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 2, 2008, Pages 504-515

  Brown, Aaron P ^a   Chen, Jergin ^a   Hitchcock, Ying J ^a   Szabo, Aniko ^a   Shrieve, Dennis C ^a   Tward, Jonathan D ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; THYROID CANCER; UNITED STATES;

EID: 39049152497     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1154     Document Type: Article

References (54)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ 2005 Cancer statistics, 2005. CA Cancer J Clin 55:10-30
2. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, Mariotto A, Feuer EJ, Edwards BK, eds, SEER Cancer Statistics Review, 1975-2002, based on November 2004 SEER data submission, posted to the SEER web site 2005. Bethesda, MD: National Cancer Institute
3. Mack WJ, Preston-Martin S, Epidemiology of thyroid cancer. In: Fagin JA, ed. Thyroid cancer. Vol 2. Boston: Kluwer Academic Publishers; 1998:1-25
4. Mehta MP, Goetowski PG, Kinsella TJ 1989 Radiation induced thyroid neoplasms 1920 to 1987: a vanishing problem? Int J Radiat Oncol Biol Phys 16:1471-1475
5. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice Jr JD 1995 Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141:259-277
6. Gilliland FD, Hunt WC, Morris DM, Key CR 1997 Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 79:564-573
7. Blankenship DR, Chin E, Terris DJ 2005 Contemporary management of thyroid cancer. Am J Otolaryngol 26:249-260
8. 2005 Thyroid Cancer Clinical Practice Guidelines in Oncology. JNCCN 3:404.
9. Schlumberger MJ 1998 Papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306
10. Kendall GM, Muirhead CR, Darby SC, Doll R, Arnold L, O'Hagan JA 2004 Epidemiological studies of UK test veterans. I. General description. J Radiol Prot 24:199-217
11. Muirhead CR, Kendall GM, Darby SC, Doll R, Haylock RG, O'Hagan JA, Berridge GL, Phillipson MA, Hunter N 2004 Epidemiological studies of UK test veterans. II. Mortality and cancer incidence. J Radiol Prot 24:219-241
12. Yoshinaga S, Mabuchi K, Sigurdson AJ, Doody MM, Ron E 2004 Cancer risks amongradiologists and radiologic technologists: review of epidemiologic studies. Radiology 233:313-321
13. Schleipman AR 2005 Occupational radiation exposure: population studies. Radiol Technol 76:185-191
14. Little JB 1993 Cellular, molecular, and carcinogenic effects of radiation. Hematol Oncol Clin North Am 7:337-352
15. Wakeford R 2004 The cancer epidemiology of radiation. Oncogene 23:6404-6428
16. Jhiang SM 2000 The RET proto-oncogene in human cancers. Oncogene 19:5590-5597
17. Beierwaltes WH, Rabbani R, Dmuchowski C, Lloyd RV, Eyre P, Mallette S 1984 An analysis of "ablation of thyroid remnants" with I-131 in 511 patients from 1947-1984: experience at University of Michigan. J Nucl Med 25:1287-1293
18. Koral KF, Adler RS, Carey JE, Beierwaltes WH 1986 Iodine-131 treatment of thyroid cancer: absorbed dose calculated from post-therapy scans. J Nucl Med 27:1207-1211
19. Breslow NE, Lubin JH, Marek P, Langholz B 1983 Multiplicative models and cohort analysis. J Am Stat Assoc 78:1-12
20. Adjadj E, Rubino C, Shamsaldim A, Le MG, Schlumberger M, de Vathaire F 2003 The risk of multiple primary breast and thyroid carcinomas. Cancer 98:1309-1317
21. Akslen LA, Glattre E 1992 Second malignancies in thyroid cancer patients: a population-based survey of 3658 cases from Norway. Eur J Cancer 28:491-495
22. Chen AY, Levy L, Goepfert H, Brown BW, Spitz MR, Vassilopoulou-Sellin R 2001 The development of breast carcinoma in women with thyroid carcinoma. Cancer 92:225-231
23. Hall P, Holm LE, Lundell G 1990 Second primary tumors following thyroid cancer. A Swedish record-linkage study. Acta Oncol 29:869-873
24. Hemminki K, Jiang Y 2001 Second primary neoplasms after 19281 endocrine gland tumours: aetiological links? Eur J Cancer 37:1886-1894
25. Li CI, Rossing MA, Voigt LF, Daling JR 2000 Multiple primary breast and thyroid cancers: role of age at diagnosis and cancer treatments (United States). Cancer Causes Control 11:805-811
26. Ronckers CM, McCarron P, Ron E 2005 Thyroid cancer and multiple primary tumors in the SEER cancer registries. Int J Cancer 117:281-288
27. Verkooijen RB, Smit JW, Romijn JA, Stokkel MP 2006 The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer. Eur J Endocrinol 155:801-806
28. Sandeep TC, Strachan MW, Reynolds RM, Brewster DH, Scelo G, Pukkala E, Hemminki K, Anderson A, Tracey E, Friis S, McBride ML, Kee-Seng C, Pompe-Kirn V, Kliewer EV, Tonita JM, Jonasson JG, Martos C, Boffetta P, Brennan P 2006 Second primary cancers in thyroid cancer patients: a multinational record linkage study. J Clin Endocrinol Metab 91:1819-1825
29. Canchola AJ, Horn-Ross PL, Purdie DM 2006 Risk of second primary malignancies in women with papillary thyroid cancer. Am J Epidemiol 163:521-527
30. Liska J, Altanerova V, Galbavy S, Stvrtina S, Brtko J 2005 Thyroid tumors: histological classification and genetic factors involved in the development of thyroid cancer. Endocr Regul 39:73-83
31. Saad MF, Ordonez NG, Rashid RK, Guido JJ, Hill Jr CS, Hickey RC, Samaan NA 1984 Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients. Medicine (Baltimore) 63:319-342
32. Edmonds CJ, Smith T 1986 The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol 59:45-51
33. Vassilopoulou-Sellin R, Palmer L, Taylor S, Cooksley CS 1999 Incidence of breast carcinoma in women with thyroid carcinoma. Cancer 85:696-705
34. 1998 Radiation dose from radiopharmaceuticals: a report of a task group of committee 2 of the ICRP. Ann ICRP 28:1-126
35. Bruno R, Giannasio P, Ronga G, Baudin E, Travagli JP, Russo D, Filetti S, Schlumberger M 2004 Sodium iodide symporter expression and radioiodine distribution in extrathyroidal tissues. J Endocrinol Invest 27:1010-1014
36. Robinson PS, Barker P, Campbell A, Henson P, Surveyor I, Young PR 1994 Iodine-131 in breast milk following therapy for thyroid carcinoma. J Nucl Med 35:1797-1801
37. Spitzweg C, Morris JC 2002 The sodium iodide symporter: its pathophysiological and therapeutic implications. Clin Endocrinol (Oxf) 57:559-574
38. Hemminki K, Boffetta P 2004 Multiple primary cancers as clues to environmental and heritable causes of cancer and mechanisms of carcinogenesis. IARC Sci Publ 157:289-297
39. Jarzab B, Wloch J, Wiench M 2001 Molecular changes in thyroid neoplasia. Folia Histochem Cytobiol 39(Suppl 2):26-27
40. Dawson DM, Lawrence EG, MacLennan GT, Amini SB, Kung HJ, Robinson D, Resnick MI, Kursh ED, Pretlow TP, Pretlow TG 1998 Altered expression of RET proto-oncogene product in prostatic intraepithelial neoplasia and prostate cancer. J Natl Cancer Inst 90:519-523
41. Meric F, Lee WP, Sahin A, Zhang H, Kung HJ, Hung MC 2002 Expression profile of tyrosine kinases in breast cancer. Clin Cancer Res 8:361-367
42. Kroll TG 2004 Molecular events in follicular thyroid tumors. Cancer Treat Res 122:85-105
43. Cybulski C, Gorski B, Huzarski T, Masojc B, Mierzejewski M, Debniak T, Teodorczyk U, Byrski T, Gronwald J, Matyjasik J, Zlowocka E, Lenner M, Grabowska E, Nej K, Castaneda J, Medrek K, Szymanska A, Szymanska J, Kurzawski G, Suchy J, Oszurek O, Witek A, Narod SA, Lubinski J 2004 CHEK2 is a multiorgan cancer susceptibility gene. Am J Hum Genet 75:1131-1135
44. Cybulski C, Wokolorczyk D, Huzarski T, Byrski T, Gronwald J, Gorski B, Debniak T, Masojc B, Jakubowska A, Gliniewicz B, Sikorski A, Stawicka M, Godlewski D, Kwias Z, Antczak A, Krajka K, Lauer W, Sosnowski M, Sikorska-Radek P, Bar K, Klijer R, Zdrojowy R, Malkiewicz B, Borkowski A, Borkowski T, Szwiec M, Narod SA, Lubinski J 2006 A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer. J Med Genet 43:863-866
45. Cybulski C, Wokolorczyk D, Huzarski T, Byrski T, Gronwald J, Gorski B, Debniak T, Masojc B, Jakubowska A, van de Wetering T, Narod SA, Lubinski J 2006 A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland. Breast Cancer Res Treat 102:119-122
46. Hall P, Holm LE, Lundell G, Bjelkengren G, Larsson LG, Lindberg S, Tennvall J, Wicklund H, Boice Jr JD 1991 Cancer risks in thyroid cancer patients. Br J Cancer 64:159-163
47. de Vathaire F, Schlumberger M, Delisle MJ, Francese C, Challeton C, de la Genardiere E, Meunier F, Parmentier C, Hill C, Sancho-Garnier H 1997 Leukaemias and cancers following iodine-131 administration for thyroid cancer. Br J Cancer 75:734-739
48. Rubino C, de Vathaire F, Dottorini ME, Hall P, Schvartz C, Couette JE, Dondon MG, Abbas MT, Langlois C, Schlumberger M 2003 Second primary malignancies in thyroid cancer patients. Br J Cancer 89:1638-1644
49. Glanzmann C 1992 Subsequent malignancies in patients treated with 131-iodine for thyroid cancer. Strahlenther Onkol 168:337-343
50. Schneider AB, Lubin J, Ron E, Abrahams C, Stovall M, Goel A, Shore-Freedman E, Gierlowski TC 1998 Salivary gland tumors after childhood radiation treatment for benign conditions of the head and neck: dose-response relationships. Radiat Res 149:625-630
51. Blanchard CM, Denniston MM, Baker F, Ainsworth SR, Courneya KS, Hann DM, Gesme DH, Reding D, Flynn T, Kennedy JS 2003 Do adults change their lifestyle behaviors after a cancer diagnosis? Am J Health Behav 27:246-256
52. Roldan Schilling V, Fernandez Abellan P, Dominguez Escribano JR, Rivas Gonzalez C, Mut Barbera E, Calatayud Cendra R 1998 Acute leukemias after treatment with radioiodine for thyroid cancer. Haematologica 83:767-768
53. Levine EG, Bloomfield CD 1992 Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Semin Oncol 19:47-84
54. Leone G, Mele L, Pulsoni A, Equitani F, Pagano L 1999 The incidence of secondary leukemias. Haematologica 84:937-945